Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-06-000243
Filing Date
2006-03-30
Accepted
2006-03-30 15:58:41
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 2005 ANNUAL REPORT o30835e6vk.htm 6-K 463243
2 GRAPHIC o30835o3083501.gif GRAPHIC 59937
3 GRAPHIC o30835o3083502.gif GRAPHIC 32871
4 GRAPHIC o30835o3083503.gif GRAPHIC 1423
5 GRAPHIC o30835o3083504.gif GRAPHIC 1117
6 GRAPHIC o30835o3083505.gif GRAPHIC 1353
7 GRAPHIC o30835o3083506.gif GRAPHIC 30342
  Complete submission text file 0001130319-06-000243.txt   640608
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 06723230
SIC: 2834 Pharmaceutical Preparations